(S1 (S (S (NP (NN N-myc)) (VP (VP (VBZ augments) (NP (NN death))) (CC and) (VP (VBZ attenuates) (NP (NP (JJ protective) (NNS effects)) (PP (IN of) (NP (NN Bcl-2))) (PP (IN in) (NP (ADJP (RB trophically) (VBN stressed)) (NN neuroblastoma) (NNS cells))))))) (. .)))
(S1 (S (S (S (NP (NN N-myc)) (VP (VBZ has) (NP (JJ proapoptotic) (NNS functions)))) (, ,) (CC yet) (S (NP (PRP it)) (VP (VBZ acts) (PP (IN as) (NP (NP (DT an) (NN oncogene)) (PP (IN in) (NP (NN neuroblastoma)))))))) (. .)))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (JJ antiapoptotic) (NNS mechanisms)) (VP (VBP have) (S (VP (TO to) (VP (VB be) (ADJP (JJ operative) (PP (IN in) (NP (NP (NN neuroblastoma) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP antagonize) (NP (NP (DT the) (JJ proapoptotic) (NNS effects)) (PP (IN of) (NP (NN N-myc))))))))))))))) (. .)))
(S1 (S (S (NP (PRP We)) (ADVP (RB conditionally)) (VP (VBD activated) (NP (NN N-myc)) (PP (IN in) (NP (NP (JJ SH-EP) (NN neuroblastoma) (NNS cells)) (VP (VBN subjected) (PP (TO to) (NP (NP (DT the) (JJ trophic) (NN stress)) (PP (IN of) (NP (NN serum) (CC or) (NN nutrient) (NN deprivation)))))))) (SBAR (IN while) (S (VP (VBG changing) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (NP (NN Bcl-2)) (, ,) (NP (NN survivin)) (CC and) (NP (ADJP (ADJP (JJ FLIP-LRB-L-RRB-)) (, ,) (ADJP (JJ antiapoptotic))) (NNS molecules))) (VP (ADVP (RB often)) (VBN overexpressed) (PP (IN in) (NP (NP (JJ poor) (NN prognosis)) (NNS neuroblastomas)))))))))))) (. .)))
(S1 (S (S (NP (NN Bcl-2)) (VP (VBD protected) (NP (NP (JJ SH-EP) (NNS cells)) (PP (IN from) (NP (NN death)))) (PP (IN during) (NP (JJ nutritional) (NN deprivation))) (PP (IN by) (S (VP (VBG activating) (NP (ADJP (RB energetically) (JJ advantageous)) (JJ oxidative) (NN phosphorylation))))))) (. .)))
(S1 (S (S (NP (NN N-myc)) (VP (VBP overrode) (NP (NP (DT the) (JJ metabolic) (NN protection)) (VP (VBN provided) (PP (IN by) (NP (JJ Bcl-2-induced) (JJ oxidative) (NN phosphorylation))) (PP (IN by) (S (VP (VP (VBG reestablishing) (NP (DT the) (JJ glycolytic) (NN phenotype))) (CC and) (VP (VBD attenuated) (NP (NP (DT the) (JJ antiapoptotic) (NN effect)) (PP (IN of) (NP (NN Bcl-2)))) (PP (IN during) (NP (JJ metabolic) (NN stress))))))))))) (. .)))
(S1 (S (S (NP (NN Survivin)) (ADVP (RB partially)) (VP (VBD antagonized) (NP (NP (DT the) (NN growth) (JJ suppressive) (NN function)) (PP (IN of) (NP (NN N-myc))) (PP (IN in) (NP (JJ SH-EP) (NN neuroblastoma) (NNS cells)))) (PP (IN during) (NP (NN serum) (NN deprivation))) (SBAR (IN whereas) (S (NP (NN FLIP-LRB-L-RRB-)) (VP (VBD did) (RB not)))))) (. .)))
(S1 (S (S (NP (DT These) (NNS findings)) (VP (VB advance) (NP (NP (PRP$ our) (NN understanding)) (PP (IN of) (NP (NP (DT the) (NNS functions)) (PP (IN of) (NP (NN N-myc))) (PP (IN in) (NP (NN neuroblastoma) (NNS cells)))))))) (. .)))
